Oppenheimer On Upcoming BioMarin Panel: Efficacy Concerns Circulate
November 23, 2015 at 14:30 PM EST
Last Friday, the FDA released briefing documents for a BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) meeting regarding drisapersen ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.